Free Trial

Exagen (XGN) SEC Filings & 10K Form

Exagen logo
$2.57
+0.14 (+5.76%)
(As of 11/1/2024 ET)

Recent Exagen SEC Filings

DateFilerForm TypeView
10/08/2024
3:39 PM
Adawi Kamal (Reporting)
Exagen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:12 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:12 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2024
4:08 PM
Adawi Kamal (Reporting)
Exagen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:15 AM
Exagen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
4:20 PM
Exagen (Filer)
Form 8-K/A
08/02/2024
7:15 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
7:02 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
8:27 AM
Exagen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
8:30 AM
Exagen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/13/2024
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
8:23 AM
Exagen (Filer)
Form ARS
04/26/2024
7:31 AM
Exagen (Filer)
Exagen (Filer)
Form DEF 14A
04/26/2024
7:32 AM
Exagen (Filer)
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
8:26 AM
Exagen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2024
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:42 PM
Exagen (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G/A
02/14/2024
6:12 AM
Exagen (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2024
5:13 AM
Exagen (Subject)
TULLIS DICKERSON CAPITAL FOCUS III, L.P. (Filed by)
Form SC 13G/A
02/09/2024
4:10 PM
Exagen (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/02/2024
2:16 PM
Cowen Financial Products LLC (Filed by)
Exagen (Subject)
Form SC 13G/A
01/22/2024
3:15 PM
Exagen (Subject)
NMSIC Co-Investment Fund, L.P. (Filed by)
Form SC 13G/A
01/08/2024
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2023
11:15 PM
Exagen (Filer)
Form EFFECT
11/29/2023
4:11 PM
Exagen (Filer)
Form 424B5
11/20/2023
7:00 AM
Exagen (Filer)
Form 424B5
11/17/2023
3:30 PM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
4:24 PM
Exagen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:XGN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners